ArticleScientific reports2026
Experimental and molecular docking evidence for the protective role of Monascus purpureus red pigments against hydroxyapatite nanoparticle-induced testicular injury in male rats.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydroxyapatite nanoparticles (HANPs) are increasingly utilized in biomedical and technological fields due to their biocompatibility and structural similarity to bone mineral. However, accumulating evidence indicates that prolonged exposure to HANPs may adversely affect the male reproductive system through oxidative stress, inflammation, apoptosis, and dysregulated autophagy. This study investigated the protective role of Monascus purpureus red pigments (RP), naturally derived bioactive compounds with antioxidant and anti-inflammatory properties, against HANP-induced testicular damage in adult male rats. Animals were orally treated with HANPs (88.3 mg/kg), RP (10, 20, or 40 mg/kg), or their combination for 50 days. Reproductive toxicity was assessed by analyzing semen quality, serum reproductive hormones, oxidative and inflammatory markers, apoptotic activity, expression of key autophagy-related genes (Beclin-1, LC3B, ULK1, and ATG9), and testicular histopathology. HANPs exposure caused significant reproductive impairment, evidenced by deteriorated semen parameters, disrupted testosterone, follicle-stimulating hormone and luteinizing hormone levels, elevated oxidative stress, increased NF-κB and caspase-3 activity, and upregulation of autophagy-related genes, accompanied by marked histopathological damage. Co-administration of RP markedly attenuated these alterations in a dose-dependent manner, with the highest dose (40 mg/kg) restoring reproductive function, redox balance, inflammatory and apoptotic status, autophagy signaling, and testicular architecture toward near-control levels. Molecular docking analysis revealed strong binding affinities of the major RP components, monascorubramine and rubropunctamine, to the autophagy-related protein LC3B, supporting a potential mechanistic role in autophagy modulation. Collectively, these findings demonstrate that M. purpureus RPs effectively protect against HANP-induced testicular toxicity through coordinated antioxidant, anti-inflammatory, anti-apoptotic, and autophagy-regulatory mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.